Cargando…

Prognostic Clinical and Biologic Features for Overall Survival after Relapse in Childhood Medulloblastoma

SIMPLE SUMMARY: Despite progress in the biology and upfront treatment of childhood medulloblastoma, relapse is almost universally fatal. No standardized treatment has so far been established for these patients. By determining which characteristics are prognostic after relapse, treatment strategies m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huybrechts, Sophie, Le Teuff, Gwénaël, Tauziède-Espariat, Arnault, Rossoni, Caroline, Chivet, Anaïs, Indersie, Émilie, Varlet, Pascale, Puget, Stéphanie, Abbas, Rachid, Ayrault, Olivier, Guerrini-Rousseau, Léa, Grill, Jacques, Valteau-Couanet, Dominique, Dufour, Christelle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795432/ https://www.ncbi.nlm.nih.gov/pubmed/33375523 http://dx.doi.org/10.3390/cancers13010053

Ejemplares similares

Role of neoadjuvant chemotherapy in metastatic medulloblastoma: a comparative study in 92 children
por: Guerrini-Rousseau, Léa, et al.
Publicado: (2020)

Clinical and molecular analysis of smoothened inhibitors in Sonic Hedgehog medulloblastoma
por: Pereira, Victor, et al.
Publicado: (2021)

MBCL-02. ROLE OF PREOPERATIVE CHEMOTHERAPY IN METASTATIC MEDULLOBLASTOMA: A COMPARATIVE STUDY IN 92 CHILDREN
por: Guerrini-Rousseau, Léa, et al.
Publicado: (2020)

Immunohistochemistry as a tool to identify ELP1-associated medulloblastoma
por: Tauziède-Espariat, Arnault, et al.
Publicado: (2022)

A sellar presentation of a WNT-activated embryonal tumor: further evidence of an ectopic medulloblastoma
por: Tauziède-Espariat, Arnault, et al.
Publicado: (2023)

MEDB-84. The French experience of ELP1-related medulloblastomas
por: Tauziède-Espariat, Arnault, et al.
Publicado: (2022)

Mesenchymal non-meningothelial tumors of the central nervous system: a literature review and diagnostic update of novelties and emerging entities
por: Tauziède-Espariat, Arnault, et al.
Publicado: (2023)

Long Time to Diagnosis of Medulloblastoma in Children Is Not Associated with Decreased Survival or with Worse Neurological Outcome
por: Brasme, Jean-Francois, et al.
Publicado: (2012)

NF1-like optic pathway gliomas in children: clinical and molecular characterization of this specific presentation
por: Lobón-Iglesias, María Jesús, et al.
Publicado: (2019)

Circular RNA profiling distinguishes medulloblastoma groups and shows aberrant RMST overexpression in WNT medulloblastoma
por: Rickert, Daniel, et al.
Publicado: (2021)

Deep intronic hotspot variant explaining rhabdoid tumor predisposition syndrome in two patients with atypical teratoid and rhabdoid tumor
por: Tauziède-Espariat, Arnault, et al.
Publicado: (2017)

Pediatric high-grade glioma MYCN is frequently associated with Li-Fraumeni syndrome
por: Guerrini-Rousseau, Léa, et al.
Publicado: (2023)

NF2 and ZFTA evaluation in the diagnostic algorithm of pediatric posterior fossa ependymoma with H3K27ME3 retained expression
por: Tauziède-Espariat, Arnault, et al.
Publicado: (2023)

DIPG-38. PATIENT-DERIVED THREE-DIMENSIONAL AVATARS REVEAL CELL-AUTONOMOUS MECHANISMS DRIVING INVASION AND METASTATIC PROGRESSION IN DIFFUSE MIDLINE GLIOMAS
por: Bruschi, Marco, et al.
Publicado: (2023)

The histomolecular criteria established for adult anaplastic pilocytic astrocytoma are not applicable to the pediatric population
por: Gareton, Albane, et al.
Publicado: (2019)

Posterior fossa ependymoma H3 K27-mutant: an integrated radiological and histomolecular tumor analysis
por: Mariet, Cassandra, et al.
Publicado: (2022)

Metastatic Medulloblastoma in Childhood: Chang's Classification Revisited
por: Dufour, Christelle, et al.
Publicado: (2012)

Expression of two parental imprinted miRNAs improves the risk stratification of neuroblastoma patients
por: Gattolliat, Charles-Henry, et al.
Publicado: (2014)

Deciphering the genetic and epigenetic landscape of pediatric bithalamic tumors
por: Tauziède‐Espariat, Arnault, et al.
Publicado: (2021)

DIPG-58. HISTONE H3 WILD-TYPE DIPG/DMG OVEREXPRESSING EZHIP EXTEND THE SPECTRUM OF DIFFUSE MIDLINE GLIOMAS WITH PRC2 INHIBITION BEYOND H3-K27M MUTATION
por: Castel, David, et al.
Publicado: (2020)

EZHIP is a specific diagnostic biomarker for posterior fossa ependymomas, group PFA and diffuse midline gliomas H3-WT with EZHIP overexpression
por: Antin, C., et al.
Publicado: (2020)

A comprehensive analysis of infantile central nervous system tumors to improve distinctive criteria for infant‐type hemispheric glioma versus desmoplastic infantile ganglioglioma/astrocytoma
por: Tauziède‐Espariat, Arnault, et al.
Publicado: (2023)

Diagnostics of pediatric supratentorial RELA ependymomas: integration of information from histopathology, genetics, DNA methylation and imaging
por: Pagès, Mélanie, et al.
Publicado: (2018)

Disseminated diffuse midline gliomas, H3K27-altered mimicking diffuse leptomeningeal glioneuronal tumors: a diagnostical challenge!
por: Tauziède-Espariat, Arnault, et al.
Publicado: (2022)

An integrative radiological, histopathological and molecular analysis of pediatric pontine histone-wildtype glioma with MYCN amplification (HGG-MYCN)
por: Tauziède-Espariat, A., et al.
Publicado: (2019)

MBRS-51. MUTATIONS IN BRPF1 FOUND IN SHH MEDULLOBLASTOMA PREVENT INTERACTION WITH TP53 AND LEADS TO RADIORESISTANCE IN VITRO
por: Vouri, Mikaela, et al.
Publicado: (2020)

High-dose thiotepa-related neurotoxicity and the role of tramadol in children
por: Maritaz, Christophe, et al.
Publicado: (2018)

Mesenchymal Transition and PDGFRA Amplification/Mutation Are Key Distinct Oncogenic Events in Pediatric Diffuse Intrinsic Pontine Gliomas
por: Puget, Stephanie, et al.
Publicado: (2012)

Papillary glioneuronal tumors: histological and molecular characteristics and diagnostic value of SLC44A1-PRKCA fusion
por: Pages, Melanie, et al.
Publicado: (2015)

Refinement of diagnostic criteria for pediatric-type diffuse high-grade glioma, IDH- and H3-wildtype, MYCN-subtype including histopathology, TP53, MYCN and ID2 status
por: Tauziède-Espariat, Arnault, et al.
Publicado: (2023)

Busulphan is active against neuroblastoma and medulloblastoma xenografts in athymic mice at clinically achievable plasma drug concentrations
por: Boland, I, et al.
Publicado: (1999)

The pediatric supratentorial MYCN-amplified high-grade gliomas methylation class presents the same radiological, histopathological and molecular features as their pontine counterparts
por: Tauziède-Espariat, A., et al.
Publicado: (2020)

DIPG-35. BIOLOGICAL MEDICINE FOR DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) ERADICATION: RESULTS OF THE THREE ARM BIOMARKER-DRIVEN RANDOMIZED BIOMEDE 1.0 TRIAL
por: Grill, Jacques, et al.
Publicado: (2020)

Supratentorial non-RELA, ZFTA-fused ependymomas: a comprehensive phenotype genotype correlation highlighting the number of zinc fingers in ZFTA-NCOA1/2 fusions
por: Tauziède-Espariat, Arnault, et al.
Publicado: (2021)

Pediatric methylation class HGNET-MN1: unresolved issues with terminology and grading
por: Tauziède-Espariat, Arnault, et al.
Publicado: (2019)

Pediatric meningiomas: A literature review and diagnostic update
por: Tauziède-Espariat, Arnault, et al.
Publicado: (2023)

Re-irradiation of recurrent pediatric ependymoma: modalities and outcomes: a twenty-year survey
por: Lobón, Maria Jesus, et al.
Publicado: (2016)

A malignant choroid plexus tumour with prevailing immature blastematous elements
por: Tauziède‐Espariat, Arnault, et al.
Publicado: (2021)

HGG-40. NF1 mosaicism in a CMMRD-patient with a glioblastoma
por: Guerrini-Rousseau, Lea, et al.
Publicado: (2022)

Diagnostic accuracy of a minimal immunohistochemical panel in at/rt molecular subtyping, correlated to dna-methylation profiling
por: Tauziède-Espariat, Arnault, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_oiebbo5tmaqm63s4l4dct78pf6